The effects of semaglutide, empagliflozin and their combination on the kidney sodium signal from magnetic resonance imaging: A prespecified, secondary analysis from a randomized, clinical trial
Open Access
- 5 January 2024
- journal article
- research article
- Published by Elsevier in Journal of Diabetes and its Complications
- Vol. 38 (2) , 108673
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Early diabetic kidney maintains the corticomedullary urea and sodium gradientPhysiological Reports, 2016
- Short‐term effects of liraglutide on kidney function and vasoactive hormones in type 2 diabetes: a randomized clinical trialDiabetes, Obesity and Metabolism, 2016
- Prognostic Value of Estimated Plasma Volume in Heart FailureJACC: Heart Failure, 2015
- Liraglutide Promotes Natriuresis but Does Not Increase Circulating Levels of Atrial Natriuretic Peptide in Hypertensive Subjects With Type 2 DiabetesDiabetes Care, 2014
- Quantitative in vivo 23Na MR imaging of the healthy human kidney: determination of physiological ranges at 3.0T with comparison to DWI and BOLDMagnetic Resonance Materials in Physics, Biology and Medicine, 2013
- Acute and chronic effects of SGLT2 blockade on glomerular and tubular function in the early diabetic ratAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2012
- Regulation of Na+/H+exchanger NHE3 by glucagon-like peptide 1 receptor agonist exendin-4 in renal proximal tubule cellsAmerican Journal of Physiology-Renal Physiology, 2009
- Sodium MRI of the human kidney at 3 TeslaMagnetic Resonance in Medicine, 2006
- Glucagon-Like Peptide-1 Is Involved in Sodium and Water Homeostasis in HumansDigestion, 2006
- Glucagon-Like Peptide 1 Induces Natriuresis in Healthy Subjects and in Insulin-Resistant Obese MenThe Journal of Clinical Endocrinology & Metabolism, 2004